Vaccines

Latest News

Promising Results for Investigational mRNA Vaccine Against CMV
Promising Results for Investigational mRNA Vaccine Against CMV

February 16th 2024

A study found that the mRNA-1647 vaccine candidate developed by Moderna elicited strong immune responses. The mRNA vaccine is now in phase 3 clinical trials to determine its effectiveness in protecting against CMV.

Alernon77-stock.adobe.com
How Vaccines are Covered in the United States

February 13th 2024

New Study Shows Efficacy of Typhoid Conjugate Vaccine
New Study Shows Efficacy of Typhoid Conjugate Vaccine

February 2nd 2024

Invivyd Seeks EUA for Additional COVID-19 Protection in Vulnerable Populations
Invivyd Seeks EUA for Additional COVID-19 Protection in Vulnerable Populations

January 16th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.